GO:0060854 branching involved in lymph vessel morphogenesis: Lymphatic Patterning, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060854 describes the coordinated growth and sprouting of lymph vessels that gives rise to the organized lymphatic system.
• Branching lymph vessel morphogenesis requires balanced pro- and anti-lymphangiogenic signals, including SEMA3A, PLXND1, MAFB, and extracellular matrix proteins such as Polydom.
• Disrupted lymphatic branching is linked to human disease, including lymphangioleiomyomatosis, lymphedema, cardiac lymphatic insufficiency, and HFpEF.
• Key experimental models include zebrafish, mouse, and human lymphatic endothelial cells, where genes such as PLXND1, MAFB, and SEMA3A have been functionally tested.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate genes in lymphatic branching.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study GO:0060854-related genes.
Description
GO:0060854, branching involved in lymph vessel morphogenesis, is a biological process that describes the coordinated growth and sprouting of lymph vessels to form the organized lymphatic system. This process is essential for establishing a functional lymphatic network that regulates tissue fluid homeostasis, immune cell trafficking, and lipid absorption. Researchers study GO:0060854 to understand how lymphatic endothelial cells acquire tip, stalk, and branch identities, and how errors in this process contribute to developmental and pathological conditions. The QuickGO definition emphasizes coordinated growth and sprouting, distinguishing this term from general lymphangiogenesis or lymphatic endothelial cell differentiation. Mechanistically, branching lymph vessel morphogenesis depends on guidance cues, extracellular matrix remodeling, and transcriptional programs that pattern the lymphatic vasculature. For example, Polydom is an extracellular matrix protein involved in lymphatic vessel remodeling, while Plexin D1 negatively regulates zebrafish lymphatic development. MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis, and SEMA3A has been implicated in lymphatic vessel maturation and lymphedema. These findings illustrate that GO:0060854 is not a single-gene process but a coordinated signaling and structural program. Because lymphatic branching is critical for organ function, its dysregulation is associated with diseases such as lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, lymphedema, and cardiac lymphatic insufficiency in HFpEF. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0060854, its genes, regulation, disease links, and experimental methods.
branching involved in lymph vessel morphogenesis At A Glance
| GO ID | GO:0060854 |
|---|---|
| GO term | branching involved in lymph vessel morphogenesis |
| Ontology | biological_process |
| Synonym | patterning of lymph vessels |
| Definition | The process of the coordinated growth and sprouting of lymph vessels giving rise to the organized lymphatic system. |
| Major function | Coordinated growth and sprouting of lymph vessels to form an organized lymphatic system. |
| Related processes | Lymphangiogenesis, lymphatic vessel remodeling, lymphatic endothelial cell migration. |
| Key regulators | SEMA3A, PLXND1, MAFB, Polydom, and extracellular matrix components. |
| Disease relevance | Lymphangioleiomyomatosis, lymphedema, cardiac lymphatic insufficiency, HFpEF. |
What Is GO:0060854?
In your own words, GO:0060854 branching involved in lymph vessel morphogenesis is the biological process by which lymphatic endothelial cells coordinately grow, sprout, and branch to build an organized lymphatic vascular network. It encompasses the patterning events that generate new lymphatic branches from existing vessels, rather than merely the initial specification of lymphatic endothelial cells.
Why Is branching involved in lymph vessel morphogenesis Important in Cell Biology?
GO:0060854 is important because branching lymph vessel morphogenesis establishes the structural basis of the lymphatic system, which is required for fluid homeostasis, immune surveillance, and lipid transport. Defects in this process are linked to human diseases including lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, lymphedema, and cardiac lymphatic insufficiency in HFpEF. Understanding the molecular control of lymphatic branching therefore has direct implications for developmental biology, vascular medicine, and therapeutic target discovery.
• Establishes the organized lymphatic vascular network required for tissue fluid homeostasis.
• Supports immune cell trafficking and lipid absorption through functional lymphatic branches.
• Dysregulation is associated with lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
• Impaired cardiac lymphatic branching contributes to HFpEF and cardiac lymphatic insufficiency.
• SEMA3A and PLXND1 signaling defects are linked to lymphedema and abnormal lymphatic patterning.
• MAFB regulates developmental and pathological lymphangiogenesis, making it a key research target.
• Polydom-mediated extracellular matrix remodeling is required for lymphatic vessel remodeling.
• Provides a model process for studying guidance cues, ECM interactions, and transcriptional control.
• CRISPR-based models enable causal testing of candidate genes in lymphatic branching.
• Supports development of precision-targeted therapies for lymphatic and cardiac diseases.
What Happens During branching involved in lymph vessel morphogenesis?
Initiation of Lymphatic Sprouting
In simple terms: Lymphatic vessels start to grow new sprouts from existing vessels.
Branching involved in lymph vessel morphogenesis begins with the selection of lymphatic endothelial tip cells that initiate sprouting from pre-existing lymphatic vessels. This step requires coordinated signaling that breaks the quiescent lymphatic endothelial cell state and promotes directed migration. In zebrafish, Plexin D1 negatively regulates lymphatic development, indicating that guidance receptor activity must be tightly controlled for proper sprouting. Polydom, an extracellular matrix protein, participates in lymphatic vessel remodeling, supporting the idea that matrix cues contribute to sprout initiation.
Guidance and Patterning of Lymphatic Branches
In simple terms: Molecular cues tell the growing lymphatic vessels where to go and how to branch.
During branching, guidance molecules such as SEMA3A and its receptor PLXND1 pattern lymphatic vessel growth and maturation. SEMA3A has been reviewed as a factor in lymphatic vessel maturation and as a candidate gene for lymphedema, highlighting its role in human lymphatic patterning. Plexin D1 negatively regulates zebrafish lymphatic development, demonstrating that repulsive guidance is required for correct branch positioning. These guidance events ensure that lymphatic branches are distributed appropriately within tissues.
Transcriptional Control of Lymphatic Patterning
In simple terms: Master transcription factors switch on the genes needed for lymphatic branching.
The transcription factor MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis. MAFB activity influences how lymphatic endothelial cells respond to patterning signals, thereby shaping branch formation. This transcriptional layer integrates extracellular cues with changes in gene expression that drive lymphatic morphogenesis. Dysregulation of such transcriptional programs can lead to abnormal lymphatic patterning in disease.
Extracellular Matrix Remodeling and Branch Stabilization
In simple terms: The tissue scaffold around lymphatic vessels is remodeled so branches can form and stabilize.
Extracellular matrix proteins such as Polydom are involved in lymphatic vessel remodeling, a key component of branching morphogenesis. Matrix remodeling allows lymphatic endothelial cells to migrate, invade, and stabilize new branches. This structural support is essential for converting initial sprouts into organized lymphatic networks. Defects in matrix remodeling can impair lymphatic vessel integrity and function.
Metabolic and Organ-Specific Modulation of Lymphatic Branching
In simple terms: Lymphatic branching can be influenced by how cells handle nutrients, especially in the heart.
Lymphatic endothelial branched-chain amino acid catabolic defects undermine cardiac lymphatic integrity and drive HFpEF, showing that metabolic pathways can modulate lymphatic branching and maintenance in the heart. Cardiac lymphatics exhibit functional plasticity in development, disease, and precision-targeted therapies, indicating that organ-specific contexts shape lymphatic branching programs. These findings expand the view of GO:0060854 beyond classical guidance cues to include metabolic regulation.
Key Genes Involved in GO:0060854 branching involved in lymph vessel morphogenesis
The following genes and proteins have been experimentally implicated in branching involved in lymph vessel morphogenesis or closely related lymphatic patterning processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEMA3A | Lymphatic vessel maturation and guidance | Candidate gene for lymphedema; regulates lymphatic patterning |
| PLXND1 | Negative regulator of zebrafish lymphatic development | Guidance receptor controlling lymphatic branch positioning |
| MAFB | Transcriptional regulator of developmental and pathological lymphangiogenesis | Controls vascular patterning in lymphatic beds |
| Polydom | Extracellular matrix protein involved in lymphatic vessel remodeling | Matrix cue for lymphatic branch stabilization |
| BCAA catabolic enzymes | Cardiac lymphatic integrity and HFpEF pathogenesis | Metabolic modulation of cardiac lymphatic branching |
| VEGFR3 | Lymphatic endothelial growth signaling | Core lymphangiogenic pathway intersecting with branching |
| PROX1 | Lymphatic endothelial identity | Transcription factor required for lymphatic programs |
| LYVE1 | Lymphatic endothelial marker | Used to identify lymphatic vessels in branching studies |
| PDPN | Lymphatic endothelial marker | Marker for lymphatic vessel visualization |
| NRP2 | Semaphorin co-receptor in lymphatic guidance | Modulates SEMA3A signaling in lymphatic maturation |
| CXCR4 | Lymphatic endothelial migration | Chemokine axis influencing lymphatic patterning |
| CCL21 | Lymphatic chemokine | Supports lymphatic network organization |
| FOXC2 | Lymphatic valve and patterning transcription factor | Linked to lymphatic patterning defects |
| GATA2 | Lymphatic endothelial transcriptional regulator | Contributes to lymphatic gene programs |
| NFATC1 | Lymphatic valve and patterning regulator | Calcineurin-NFAT signaling in lymphatic morphogenesis |
| ITGA9 | Lymphatic valve formation | Matrix-integrin interactions in lymphatic remodeling |
| EFNB2 | Lymphatic patterning guidance | Ephrin signaling in vascular patterning |
How Is branching involved in lymph vessel morphogenesis Regulated?
Branching involved in lymph vessel morphogenesis is regulated by a combination of guidance cues, transcriptional programs, extracellular matrix interactions, and metabolic signals. SEMA3A and PLXND1 provide repulsive guidance that shapes lymphatic branch positioning. MAFB acts as a transcriptional regulator of developmental and pathological lymphangiogenesis. Polydom-mediated extracellular matrix remodeling supports lymphatic vessel remodeling. In the heart, branched-chain amino acid catabolic defects impair cardiac lymphatic integrity and contribute to HFpEF, indicating metabolic regulation of lymphatic branching. Cardiac lymphatics also display functional plasticity in development and disease, suggesting context-dependent regulatory mechanisms.
branching involved in lymph vessel morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SEMA3A | Lymphedema and lymphatic maturation defects | Knockout or point-mutation human lymphatic endothelial cells |
| PLXND1 | Abnormal lymphatic development | Zebrafish knockout and rescue |
| MAFB | Pathological lymphangiogenesis | Knockout mouse and lymphatic endothelial cells |
| Polydom | Lymphatic vessel remodeling defects | Knockout mouse and ECM assays |
| BCAA catabolic enzymes | Cardiac lymphatic insufficiency and HFpEF | Cardiac lymphatic endothelial cell knockout |
Lymphangioleiomyomatosis and Idiopathic Pulmonary Fibrosis
Lymphatic involvement is a recognized feature of lymphangioleiomyomatosis, and lymphatic abnormalities also occur in idiopathic pulmonary fibrosis. These conditions highlight how disrupted lymphatic patterning and remodeling can contribute to lung disease pathology. Research into GO:0060854-related genes may clarify mechanisms of lymphatic involvement in these diseases.
Lymphedema and SEMA3A Variants
SEMA3A has been reviewed as a factor in lymphatic vessel maturation and as a candidate gene for lymphedema, with rare causative variants identified in families. This links defective lymphatic guidance and maturation to human lymphatic disease. PLXND1, a SEMA3A receptor, negatively regulates zebrafish lymphatic development, further supporting the importance of this axis in lymphatic patterning.
Cardiac Lymphatic Insufficiency and HFpEF
Lymphatic endothelial branched-chain amino acid catabolic defects undermine cardiac lymphatic integrity and drive HFpEF. Cardiac lymphatics show functional plasticity in development, disease, and precision-targeted therapies, indicating that lymphatic branching and maintenance are relevant to heart failure. These findings position GO:0060854-related processes as potential therapeutic targets in cardiac disease.
Pathological Lymphangiogenesis
MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis, suggesting that transcriptional control of lymphatic branching is relevant to disease-associated lymphangiogenesis. Polydom-mediated lymphatic vessel remodeling also has implications for pathological lymphatic remodeling. Together, these studies indicate that GO:0060854 mechanisms can be co-opted in disease.
From branching involved in lymph vessel morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for lymphatic branching? | CRISPR knockout in human lymphatic endothelial cells or zebrafish |
| Does a specific variant alter lymphatic patterning? | Point-mutation knock-in in lymphatic endothelial cells |
| Does a gene fusion or tag affect protein localization during branching? | Tagged knock-in in lymphatic endothelial cells |
| Does overexpression of a guidance cue alter branch formation? | Overexpression in zebrafish or mouse lymphatic endothelium |
| Which transcriptional programs control lymphatic patterning? | Knockout plus RNA-seq in lymphatic endothelial cells |
| How does metabolic stress affect cardiac lymphatic branching? | Cardiac lymphatic endothelial cell knockout and HFpEF models |
How to Study the branching involved in lymph vessel morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on lymphatic branching | Testing candidate gene requirement |
| CRISPR knock-in | Effects of specific variants or tags | Modeling lymphedema-associated variants |
| RNA-seq | Transcriptional changes in lymphatic endothelial cells | Identifying downstream programs of MAFB and other regulators |
| Live imaging in zebrafish | Dynamic lymphatic sprouting and guidance | Studying PLXND1 and guidance cues |
| Immunofluorescence | Lymphatic vessel morphology and marker expression | Visualizing branch patterns in tissues |
| Metabolic assays | BCAA catabolism and lymphatic integrity | Cardiac lymphatic studies in HFpEF models |
| Human variant analysis | Rare variants in lymphatic genes | Identifying lymphedema-associated mutations |
| ECM remodeling assays | Polydom-dependent matrix changes | Studying lymphatic vessel remodeling |
Genetic Knockout and Knock-in Models
CRISPR knockout and knock-in models allow causal testing of genes implicated in GO:0060854. For example, PLXND1 knockout in zebrafish revealed its negative regulatory role in lymphatic development. MAFB knockout studies demonstrated its role in developmental and pathological lymphangiogenesis. Polydom knockout models showed defects in lymphatic vessel remodeling.
Transcriptomic and Imaging Approaches
RNA-seq of lymphatic endothelial cells can identify transcriptional programs downstream of MAFB and other regulators of lymphatic patterning. Imaging of lymphatic vessels using markers such as LYVE1 and PDPN allows visualization of branch morphology. Zebrafish live imaging is particularly useful for studying dynamic lymphatic sprouting and guidance.
Metabolic and Functional Assays
Metabolic assays in cardiac lymphatic endothelial cells can reveal how branched-chain amino acid catabolism affects lymphatic integrity. Functional assays of lymphatic permeability and sprouting can link molecular changes to branching phenotypes. These approaches help connect GO:0060854 mechanisms to organ-level function.
Human Genetics and Variant Analysis
Analysis of rare variants in SEMA3A and related genes in lymphedema families can identify human mutations affecting lymphatic maturation. Combining human genetics with functional assays in lymphatic endothelial cells strengthens causal inference. Such studies can guide the design of CRISPR point-mutation models.
How CRISPR Can Be Used to Study GO:0060854 branching involved in lymph vessel morphogenesis
Knockout
CRISPR knockout of genes such as PLXND1, MAFB, or Polydom in lymphatic endothelial cells or zebrafish can reveal their requirement for branching involved in lymph vessel morphogenesis. Knockout studies have shown that PLXND1 negatively regulates lymphatic development and that MAFB controls lymphatic patterning. Polydom knockout affects lymphatic vessel remodeling.
Point Mutation
Point-mutation knock-in can model human variants, such as those in SEMA3A associated with lymphedema, to test their effects on lymphatic maturation and branching. This approach allows precise assessment of whether a specific amino acid change alters guidance or receptor interactions. Such models complement human genetic studies.
Knock-in
Tagged knock-in of lymphatic genes can be used to track protein localization and interactions during branching. For example, tagging Polydom or MAFB can reveal their distribution in remodeling lymphatic vessels. Knock-in reporters can also monitor transcriptional activity in live models.
Overexpression
Overexpression of guidance cues such as SEMA3A or matrix proteins like Polydom can test sufficiency for altering lymphatic branching. Overexpression in zebrafish or mouse lymphatic endothelium can reveal gain-of-function phenotypes. These models help distinguish drivers from modifiers of GO:0060854.
How EDITGENE Supports branching involved in lymph vessel morphogenesis Research
Researchers studying branching involved in lymph vessel morphogenesis-related genes often need to determine whether a candidate gene is causally involved in lymphatic patterning, whether a specific variant alters protein function, or whether overexpression is sufficient to drive branching phenotypes. EDITGENE provides CRISPR-based cell models and screening services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for branching involved in lymph vessel morphogenesis research.
Frequently Asked Questions About branching involved in lymph vessel morphogenesis
What is GO:0060854 branching involved in lymph vessel morphogenesis?
GO:0060854 is a biological process describing the coordinated growth and sprouting of lymph vessels to form the organized lymphatic system.
What genes are involved in branching involved in lymph vessel morphogenesis?
Key genes include SEMA3A, PLXND1, MAFB, and Polydom, which regulate guidance, transcription, and extracellular matrix remodeling during lymphatic branching.
How is branching involved in lymph vessel morphogenesis regulated?
It is regulated by guidance cues such as SEMA3A-PLXND1, transcription factors like MAFB, extracellular matrix proteins such as Polydom, and metabolic signals including BCAA catabolism.
What diseases are linked to defective lymphatic branching?
Lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, lymphedema, and cardiac lymphatic insufficiency in HFpEF have been linked to lymphatic patterning defects.
Which model organisms are used to study lymphatic branching?
Zebrafish and mouse models are widely used, along with human lymphatic endothelial cell cultures.
How can CRISPR be used to study GO:0060854?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes in lymphatic branching.
What is the role of SEMA3A in lymphatic vessel morphogenesis?
SEMA3A is involved in lymphatic vessel maturation and is a candidate gene for lymphedema.
What is the role of PLXND1 in lymphatic development?
PLXND1 negatively regulates zebrafish lymphatic development, shaping branch positioning.
What is the role of MAFB in lymphangiogenesis?
MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis.
What is the role of Polydom in lymphatic remodeling?
Polydom is an extracellular matrix protein involved in lymphatic vessel remodeling.
Conclusion
GO:0060854 branching involved in lymph vessel morphogenesis is a central biological process that builds the organized lymphatic network through coordinated sprouting, guidance, transcriptional control, and matrix remodeling. Its dysregulation is linked to lymphangioleiomyomatosis, lymphedema, idiopathic pulmonary fibrosis, and cardiac lymphatic insufficiency in HFpEF. Continued research using CRISPR models and multi-omics approaches will clarify how individual genes contribute to lymphatic branching and how these mechanisms can be targeted therapeutically.
References
- 1. Guo X et al.. 2025. Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine Cardiac Lymphatic Integrity and Drive HFpEF.. Circulation 151(23):1651-1666 PMID: 40166847
- 2. Glasgow CG et al.. 2008. Lymphatic involvement in lymphangioleiomyomatosis.. Ann N Y Acad Sci 1131:206-14 PMID: 18519973
- 3. Morooka N et al.. 2017. Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.. Circ Res 120(8):1276-1288 PMID: 28179430
- 4. Britto DD et al.. 2022. Plexin D1 negatively regulates zebrafish lymphatic development.. Development 149(21) PMID: 36205097
- 5. Hao L et al.. 2026. Cardiac lymphatics: functional plasticity in development, disease, and precision-targeted therapies.. Basic Res Cardiol 121(2):231-248 PMID: 41571961
- 6. Dieterich LC et al.. 2020. Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis.. Angiogenesis 23(3):411-423 PMID: 32307629
- 7. Glasgow CG et al.. 2012. Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.. Eur Respir Rev 21(125):196-206 PMID: 22941884
- 8. Ricci M et al.. 2020. Review of the function of SEMA3A in lymphatic vessel maturation and its potential as a candidate gene for lymphedema: Analysis of three families with rare causative variants.. Lymphology 53(2):63-75 PMID: 33190429
